SG11202113009PA - Preparation of preliposomal annamycin lyophilizate - Google Patents
Preparation of preliposomal annamycin lyophilizateInfo
- Publication number
- SG11202113009PA SG11202113009PA SG11202113009PA SG11202113009PA SG11202113009PA SG 11202113009P A SG11202113009P A SG 11202113009PA SG 11202113009P A SG11202113009P A SG 11202113009PA SG 11202113009P A SG11202113009P A SG 11202113009PA SG 11202113009P A SG11202113009P A SG 11202113009PA
- Authority
- SG
- Singapore
- Prior art keywords
- preliposomal
- annamycin
- lyophilizate
- preparation
- preliposomal annamycin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962868184P | 2019-06-28 | 2019-06-28 | |
| PCT/US2020/039620 WO2020264160A1 (en) | 2019-06-28 | 2020-06-25 | Preparation of preliposomal annamycin lyophilizate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202113009PA true SG11202113009PA (en) | 2021-12-30 |
Family
ID=74061071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202113009PA SG11202113009PA (en) | 2019-06-28 | 2020-06-25 | Preparation of preliposomal annamycin lyophilizate |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20220105115A1 (en) |
| EP (1) | EP3989978A4 (en) |
| JP (1) | JP2022538865A (en) |
| KR (1) | KR20220027969A (en) |
| CN (1) | CN114641296A (en) |
| AU (1) | AU2020303572A1 (en) |
| BR (1) | BR112021026506A2 (en) |
| CA (1) | CA3142510A1 (en) |
| EA (1) | EA202193193A1 (en) |
| IL (1) | IL289432A (en) |
| MX (1) | MX2021015668A (en) |
| SG (1) | SG11202113009PA (en) |
| TW (1) | TW202114703A (en) |
| WO (1) | WO2020264160A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202113005SA (en) | 2019-06-28 | 2021-12-30 | Univ Texas | Method of reconstituting liposomal annamycin |
| AU2020303572A1 (en) | 2019-06-28 | 2022-01-20 | Board Of Regents, The University Of Texas System | Preparation of preliposomal Annamycin lyophilizate |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5902604A (en) * | 1995-06-06 | 1999-05-11 | Board Of Regents, The University Of Texas System | Submicron liposome suspensions obtained from preliposome lyophilizates |
| WO2001032145A1 (en) * | 1999-10-29 | 2001-05-10 | Board Of Regents, The University Of Texas System | Method of cancer treatment |
| ES2376875T3 (en) | 2003-02-14 | 2012-03-20 | Children's Hospital & Research Center At Oakland | Vehicle for administration of lipophilic drugs and methods of use thereof |
| AU2012322797B2 (en) | 2011-10-14 | 2016-04-21 | Genentech, Inc. | Uses for and article of manufacture including HER2 dimerization inhibitor Pertuzumab |
| US8926994B2 (en) * | 2011-12-07 | 2015-01-06 | The Methodist Hospital Research Institute | Mesoporous silicon particles for the presentation of tumor antigens and adjuvant for anti-cancer immunity |
| SG11202113005SA (en) | 2019-06-28 | 2021-12-30 | Univ Texas | Method of reconstituting liposomal annamycin |
| AU2020303572A1 (en) | 2019-06-28 | 2022-01-20 | Board Of Regents, The University Of Texas System | Preparation of preliposomal Annamycin lyophilizate |
-
2020
- 2020-06-25 AU AU2020303572A patent/AU2020303572A1/en active Pending
- 2020-06-25 SG SG11202113009PA patent/SG11202113009PA/en unknown
- 2020-06-25 JP JP2021577269A patent/JP2022538865A/en active Pending
- 2020-06-25 WO PCT/US2020/039620 patent/WO2020264160A1/en active Application Filing
- 2020-06-25 EA EA202193193A patent/EA202193193A1/en unknown
- 2020-06-25 EP EP20830959.1A patent/EP3989978A4/en active Pending
- 2020-06-25 BR BR112021026506A patent/BR112021026506A2/en unknown
- 2020-06-25 MX MX2021015668A patent/MX2021015668A/en unknown
- 2020-06-25 CA CA3142510A patent/CA3142510A1/en active Pending
- 2020-06-25 KR KR1020227001740A patent/KR20220027969A/en unknown
- 2020-06-25 CN CN202080046256.XA patent/CN114641296A/en active Pending
- 2020-06-29 TW TW109121839A patent/TW202114703A/en unknown
-
2021
- 2021-12-17 US US17/554,550 patent/US20220105115A1/en active Pending
- 2021-12-27 IL IL289432A patent/IL289432A/en unknown
-
2023
- 2023-10-05 US US18/481,946 patent/US11951118B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3989978A4 (en) | 2023-05-10 |
| CA3142510A1 (en) | 2020-12-30 |
| US20220105115A1 (en) | 2022-04-07 |
| TW202114703A (en) | 2021-04-16 |
| CN114641296A (en) | 2022-06-17 |
| JP2022538865A (en) | 2022-09-06 |
| KR20220027969A (en) | 2022-03-08 |
| WO2020264160A1 (en) | 2020-12-30 |
| EP3989978A1 (en) | 2022-05-04 |
| IL289432A (en) | 2022-02-01 |
| EA202193193A1 (en) | 2022-03-30 |
| MX2021015668A (en) | 2022-04-18 |
| BR112021026506A2 (en) | 2022-02-15 |
| US20240041909A1 (en) | 2024-02-08 |
| US11951118B2 (en) | 2024-04-09 |
| AU2020303572A1 (en) | 2022-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286218A (en) | Solid state forms of ripretinib | |
| GB202106894D0 (en) | Process for the preparation of 3alpha-hydroxy-5#LPHA-Pregnan-20-one (brexanolone) | |
| IL289432A (en) | Preparation of preliposomal annamycin lyophilizate | |
| EP4041386A4 (en) | Wet preparation of radiotherapy sources | |
| EP4065127A4 (en) | Mixture of hmos | |
| EP3894768C0 (en) | Methods of cryo-curing | |
| IL256948B (en) | Estimation of tissue thickness | |
| SI3749673T1 (en) | Crystalline form of bictegravir sodium | |
| GB2588505B (en) | Preparation of psilocybin | |
| GB201906176D0 (en) | Gating of radiotherepy | |
| GB2575067B (en) | Selection of identifiers | |
| ZA202105399B (en) | Use of spiropidion | |
| IL287507A (en) | Methods for preparation of jasmonate compounds | |
| IL289904A (en) | Process for the preparation of biphenylamines | |
| EP3894418A4 (en) | Preparation of triiodosilanes | |
| IL276107A (en) | Solid forms of fasoracetam | |
| SG11202105136WA (en) | Application of chidamide | |
| SG11202107366QA (en) | Actuation of execution units | |
| EP3843630A4 (en) | Analysing symmetry of limb function | |
| GB201912411D0 (en) | Crystalline forms of ivosidenib | |
| PT3868366T (en) | Coated solid preparation | |
| GB201906969D0 (en) | Tissue splayer | |
| GB201910250D0 (en) | Preparation of antibacterial compounds | |
| GB201907732D0 (en) | Preparation of antibacterial compounds | |
| IL288083A (en) | External preparation |